Poliklinik Koşullarında Uykusuzluğa Yaklaşım ve Pratik Öneriler
Özet
Poliklinik koşullarında uykusuzluk bozukluğunun (insomnia) tanımı, sınıflandırılması, etiyolojisi, klinik değerlendirmesi ve tedavisine yönelik kapsamlı pratik öneriler sunan makalede, uykunun genel sağlık üzerindeki hayati işlevleri ve tedavi edilmeyen uykusuzluğun küresel bir tehdit oluşturduğu vurgulanmaktadır. Genel nüfusun %10-20'sini etkileyen bu rahatsızlık için güncel ICSD-3 ve DSM-5 tanı sistemleri, birincil-ikincil ayrımını kaldırarak uykusuzluğu kendi içinde kronik bir bozukluk olarak ele almakta; tanı için haftada en az 3 kez ve en az 3 ay süre koşulu aramaktadır. Yorgunluk, dikkat dağınıklığı ve işlevsellik kaybına yol açan bozukluğun etiyolojisinde; Spielman'ın Üç Faktörlü Modeli, Nörobilişsel ve Hiperarousal modelleri öne çıkmakta ve uykusuzluğun psikofizyolojik yatkınlık, stresörler ve uyumsuz davranışlar zinciriyle kronikleştiği belirtilmektedir. Değerlendirmede detaylı klinik öykü ve uyku günlükleri kritik rol oynar. Farmakolojik olmayan yaklaşımlar (uyku hijyeni, uyaran kontrolü, gevşeme yöntemleri, paradoksal niyetlenme) tedavinin birinci basamağı ve en güvenli seçeneğidir. İlaç tedavileri ise tolerans ve bağımlılık riskleri nedeniyle hastaya özgü, en düşük dozda ve 2-4 hafta gibi kısa süreli planlanmalıdır.
This article presents comprehensive practical recommendations on the definition, classification, etiology, clinical evaluation, and treatment of insomnia in outpatient settings, emphasizing that sleep is a vital biological function for health and untreated insomnia poses a global threat. Affecting 10-20% of the general population, current ICSD-3 and DSM-5 diagnostic systems eliminate the primary-secondary distinction, treating insomnia as a chronic disorder in its own right, requiring a frequency of at least 3 times a week for at least 3 months for diagnosis. The condition, which causes fatigue, attention impairment, and loss of functionality, is explained through the Three-Factor Model of Spielman, Neurocognitive, and Hyperarousal models, indicating that insomnia becomes chronic via a chain of psychophysiological predisposition, stressors, and maladaptive behaviors. Detailed clinical history and sleep diaries play a critical role in evaluation. Non-pharmacological approaches (sleep hygiene, stimulus control, relaxation techniques, paradoxical intention) are the first-line and safest treatment options. Pharmacological treatments should be planned case-specifically at the lowest effective dose for a short duration of 2-4 weeks due to tolerance and dependence risks.
Referanslar
Davies SK, Ang JE, Revell VL, et al. Effect of sleep deprivation on the human metabolome. Proc Natl Acad Sci U S A. 2014;111(29):10761-10766. doi:10.1073/pnas.1402663111.
Cincin A, Sari I, Oğuz M, et al. Effect of acute sleep deprivation on heart rate recovery in healthy young adults. Sleep Breath. 2015;19(2):631-6. doi:10.1007/s11325-014-1066-x.
Hsu CY, Chen YT, Chen MH, et al. The association between insomnia and increased future cardiovascular events:A nationwide population-based study. Psychosom Med. 2015;77(7):743-51. doi:10.1097/PSY.0000000000000199.
Araújo T, Jarrin DC, Leanza Y, et al. Qualitative studies of insomnia: Current state of knowledge in the field. Sleep Med Rev. 2017;31:58-69. doi:10.1016/j.smrv.2016.01.003.
American Academy of Sleep Medicine (AASM) (2014) International Classification of Sleep Disorders, Third Edition (ICSD-3). Darien, IL:American Academy of Sleep Medicine.
Saddichha S. Diagnosis and treatment of chronic insomnia. Ann Indian Acad Neurol. 2010;13(2):94-102.
American Psychiatric Associaiton (2013) Diagnostic and Statistical Manual of Mental Disorders, DSM-5. American Publishing, Washington DC.
Yetkin, S. (2016). Uykusuzluk (İnsomnia). Erhan Akıncı, Fatma Özlem Orhan, Mehmet Murat Demet (Ed.), Uyku Bozuklukları (s. 67-84). Ankara: TPD Petek Yayıncılık Kurulu
Chigome AK, Nhira S, Meyer H. An overview of insomnia and its management. S Afr Pharm J. 2018;85(2):32-38
Ohayon MM. Epidemiology of insomnia:What we know and what we still need to learn. Sleep Med Rev. 2002;6:97-111.
Benbir G, Demir AU, Aksu M, et al. Prevalence of insomnia and its clinical correlates in a general population in Turkey. Psychiatry Clin Neurosci. 2015;69:543-552.
Duran S, Erkin Ö. Psychologic distress and sleep quality among adults in Turkey during the COVID-19 pandemic. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107:110254. doi:10.1016/j.pnpbp.2021.110254.
O’Malley MB, O’Malley EB. Clinical features, diagnosis, and differential diagnosis. In: Attarian H. (Eds) Clinical Handbook of Insomnia. (27-39). Current Clinical Neurology. Springer, Cham.
Winkelman JW. Clinical Practice. Insomnia disorder. N Engl J Med. 2015;373(15):1437-1444. doi:10.1056/NEJMcp1412740.
Roth T, Coulouvrat C, Hajak G, et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/ International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry.2011;69(6):592-600.
Ohayon MM, Guilleminault C. Epidemiyology of sleep disorders. Lee-Chiong,Teofilo (Ed):Sleep: A Compherensive Handbook. (s:73-82) New Jersey, John Wiley and Sons.
Hublin C, Partinen M, Koskenvuo M, et al. Heritability and Mortality Risk of Insomnia-Related Symptoms: A Genetic Epidemiologic Study in a Population-Based Twin Cohort. Sleep. 2011;34: 957-964. doi:10.5665/SLEEP.1136
Wing YK, Zhang J, Lam SP, et al. Familial aggregation and heritability of insomnia in a community-based study. Sleep Med. 2012;13(8):985-90. doi:10.1016/j.sleep.2012.04.013.
Harvey AG. A cognitive model of insomnia. Behav Res Ther. 2002;40:869-893.
Harvey AG, Tang NK, Browning L. Cognitive approaches to insomnia. Clin Psychol Rev. 2005;25:593-611.
Espie CA, Broomfield NM, MacMahon KMA, et al. The attention intention- effort pathway in the development of psychophysiologic insomnia: an invited theoretical review. Sleep Med Rev. 2006;10:215-245.
Niall M. Broomfield NM, Espie CA. Towards a valid, reliable measure of sleep effort. J Sleep Res. 2005;14:401-407.
Morin CM, Bélanger L, LeBlanc M, et al. The natural history of insomnia: a population-based 3-year longitudinal study. Archives of Internal Medicine. 2009;169:447-453.
Morphy H, Dunn KM, Lewis M, et al. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep. 2007;30(3):274-80.
Spielman A, Caruso L, Glovinsky P. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10:541-553.
Perlis ML, Merica H, Smith MT, et al. Beta EEG activity and insomnia. Sleep Med Rev. 2001;5:365-376.
Perlis M, Shaw PJ, Cano G, Espie CA, (2011). Models of Insomnia. (Meir H. Kryger, Thomas Roth, William C. Dement eds). Principles and Practice of Sleep Medicine W.B. ( 5th ed., pp850-865). Saunders.
Lack LC, Gradisar M, van Someren EJW, et al. The relationship between insomnia and body temperatures. Sleep Med Rev. 2008;12:307-317.
Vgontzas AN, Chrousos GP. Sleep, the hypothalamic-pituaitary-adrenal axis and cytokines:multiple interactions and disturbances in sleep disorders. Endocrinal Metab Clin North Am. 2002;31:15-36.
Vgontaz AN, Bixler EO, Lin HM, et al. Chronic insomnia is associated with nytohemeral activation of hypothalamic pituaitary-adrenal axis: clinic implicaiton. J Clin Endoncrinol Metab. 2001;86:3787-3794.
Aydın H. (2013). Uykusuzluk. Bağlam Yayınları.
Malan L, Dlamini N. Clinical practice guidelines for insomnia disorder. South African Family Practice. 2017;59(3):45-51.
Vyas UK. Non-pharmacological management of insomnia. Br J Med Pract. 2013;6(3):a623.
Stepanski EJ, Wyatt JK. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev. 2003;7:215-225.
Aslan S. (2020). Uyku, uykusuzluk ve rüyalar. (2. Baskı). Ankara:Akılçelen Kitaplar.
Sateia MS, Buysse DJ, Krystal AD, et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.J Clin Sleep Med. 2017;13(2):307-349. doi:10.5664/jcsm.6470.
Demet MM, Akıncı E. (2016). Uyku bozukluklarının tedavisinde kullanılan ilaçlar. Erhan Akıncı, Fatma Özlem Orhan, Mehmet Murat Demet (Ed.), Uyku Bozuklukları (s. 231-252). Ankara: TPD Petek Yayıncılık Kurulu.
Khanam S, Das M. Insomnia and its management: A systematic review. IP Int J Compr Adv Pharmacol. 2021;6(1):10-21. doi:10.18231/j.ijcaap.2021.003.
Mayer G,Wang-Weigand S, Roth-Schechter, et al. Efficacy and safety of 6-month nightly ramelton administration in adults with chronic primary insomnia. Sleep. 2009;32:351-360.
Zammit G, Wang-Weigand S, Rosenthal M, et al. Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia. J Clin Sleep Med. 2009;5:34-40.
